FDA Approval

Showing 237 articles
Business

Robinhood's Triple Play: From Trump Accounts to SpaceX IPO and Tokenization

Robinhood is positioning itself at the center of three major financial shifts: potentially administering new federal savings accounts, vying for a key role in SpaceX's blockbuster IPO, and expanding into tokenized assets. This strategic pivot could redefine the fintech's role from a trading app to a core financial infrastructure player.

Business

NetEase Shares Dip: A Buying Opportunity or a Sign of Deeper Challenges?

Following a significant pullback, NetEase (SEHK: 9999) shares are trading at levels that some analysts deem undervalued. We examine the financial models, peer comparisons, and the broader sector headwinds facing the Chinese gaming giant to assess if the current price presents a strategic entry point for long-term investors.